Matthew Witkowski

15PUBLICATIONS

78CO-AUTHORS

Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Cancer geneticsGene and molecular therapyAdolescent health

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (15)

Sort by Publication Date:

|Jul 01, 2026

FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia.

|Apr 14, 2026

3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia.

Yohana E Ghebrechristos, Nikki A Evensen, Romane S Cathelin

|Mar 30, 2026

Incorporating ALL Biology into Treatment Decisions: Next Steps toward Targeted Therapy in Adult ALL.

Caner Saygin, Matthew T Witkowski, Sinan Cetin

|Oct 15, 2025

Small-molecule OPA1 inhibitors reverse mitochondrial adaptations to overcome therapy resistance in acute myeloid leukemia.

Sofia La Vecchia, Saurav Doshi, Petros Antonoglou

|Jun 27, 2025

Multipotent lineage potential in B cell acute lymphoblastic leukemia is associated with distinct cellular origins and clinical features.

Ilaria Iacobucci, Andy G X Zeng, Qingsong Gao

|Nov 19, 2024

Bivalent CD47 immunotoxin for targeted therapy of T-cell acute lymphoblastic leukemia.

Jihong Ma, Zhaohui Wang, Danielle Mintzlaff

Pageof 3

Frequent Collaborators

Iannis Aifantis

William L Carroll

Charles G Mullighan

Aristotelis Tsirigos

David T Teachey

John E Dick

Ilaria Iacobucci

Maarten Fornerod

Gabriel Robbins

Esther A Obeng

Frequent Collaborators

Iannis Aifantis

William L Carroll

Charles G Mullighan

Aristotelis Tsirigos